Free-cash-flow proxy increased 54.7%
Free-cash-flow proxy changed +54.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +54.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +52.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -31.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Capital expenditure changed -89.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +28.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -16.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed -662 basis points from the comparable as-filed period.
Shares outstanding changed -3.2% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes. This reverses 7 consecutive comparable moves in the opposite direction.
Operating margin changed +3699 basis points from the comparable as-filed period.
Research & development changed -32.2% from the comparable as-filed period.
Inventory / revenue changed +2177 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -67.0% from the comparable as-filed period.
Current liabilities changed -14.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
SBC / revenue changed -3684 basis points from the comparable as-filed period.
Capex / revenue changed -877 basis points from the comparable as-filed period.
Free-cash-flow margin changed +8350 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +7473 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed -15.2% from the comparable as-filed period.
Gross profit changed -19.9% from the comparable as-filed period.
R&D / revenue changed -2148 basis points from the comparable as-filed period.
Receivables / revenue changed -1932 basis points from the comparable as-filed period.
Working capital changed -15.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed -15.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed +10.3% from the comparable as-filed period.
Inventory changed -1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +40 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.